Dayton Misfeldt

Overview

Dayton Misfeldt received an average of $457K in total compensation at Sunesis Pharmaceuticals between 2018 and 2019.

Source: SEC filing on April 28, 2020.

Related executives

We found 14 more executives who work or worked at Sunesis Pharmaceuticals.

Ivor Royston

Sunesis Pharmaceuticals

Chief Executive Officer

Lisa Rojkjaer

Sunesis Pharmaceuticals

Chief Medical Officer

Daniel Chevallard

Sunesis Pharmaceuticals

Chief Financial Officer

Par Hyare

Sunesis Pharmaceuticals

Chief Executive Officer

Judith Fox

Sunesis Pharmaceuticals

Chief Scientific Officer

William Quinn

Sunesis Pharmaceuticals

Chief Financial Officer

Daniel Swisher

Sunesis Pharmaceuticals

Chief Executive Officer

Eric Bjerkholt

Sunesis Pharmaceuticals

Chief Financial Officer

News

You may also like